SIV infection of rhesus macaques results in dysfunctional T- and B-cell responses to neo and recall Leishmania major vaccination - PubMed (original) (raw)
SIV infection of rhesus macaques results in dysfunctional T- and B-cell responses to neo and recall Leishmania major vaccination
Nichole R Klatt et al. Blood. 2011.
Abstract
HIV infection is characterized by immune system dysregulation, including depletion of CD4+ T cells, immune activation, and abnormal B- and T-cell responses. However, the immunologic mechanisms underlying lymphocytic dysfunctionality and whether it is restricted to immune responses against neo antigens, recall antigens, or both is unclear. Here, we immunized SIV-infected and uninfected rhesus macaques to induce immune responses against neo and recall antigens using a Leishmania major polyprotein (MML) vaccine given with poly-ICLC adjuvant. We found that vaccinated SIVuninfected animals induced high frequencies of polyfunctional MML-specific CD4+ T cells. However, in SIV-infected animals, CD4+ T-cell functionality decreased after both neo (P = .0025) and recall (P = .0080) MML vaccination. Furthermore, after SIV infection, the frequency of MML-specific antibody-secreting classic memory B cells was decreased compared with vaccinated, SIV-uninfected animals. Specifically, antibody-secreting classic memory B cells that produced IgA in response to either neo (P = .0221) or recall (P = .0356) MML vaccinations were decreased. Furthermore, we found that T-follicular helper cells, which are essential for priming B cells, are preferentially infected with SIV. These data indicate that SIV infection results in dysfunctional T-cell responses to neo and recall vaccinations, and direct SIV infection of T-follicular helper cells, both of which probably contribute to deficient B-cell responses and, presumably, susceptibility to certain opportunistic infections.
Figures
Figure 1
Loss of multifunctional MML-specific CD4+ T cells after SIV infection in neo-vaccinated animals. Flow cytometric analysis of MML-specific memory and effector (CD28+CD95+ and CD28−CD95+/−) CD4+ T cells 2 weeks after neo MML vaccinations by production of CD40L, IFNγ, IL-2, TNFα, or a combination. (A) Pie charts represent fraction of cells that have 4 (yellow), 3 (cyan), 2 (blue), or 1 (purple) function(s). P value calculated by partial permutation test. (B) Delineation of the 15 possible cytokine combinations is shown for SIV− (green) and SIV+ (black). Dots represent individual RM responses. (C) Student t test results between SIV− and SIV+ cytokine responses corresponding to panel B. Pink shading represents a significant P value less than .05. (D) Total frequency of cytokine producing memory and effector CD4+ T cells for SIV− (green) and SIV+ (black) in response to MML stimulation. P values represent partial permutation test results (A) or Student t test results (C). MML-specific responses from uninfected animals are based on data from group 1 and group 3 animals before SIV infection.
Figure 2
Loss of multifunctional MML-specific CD4+ T cells after SIV infection in recall-vaccinated animals. Flow cytometric analysis of MML-specific memory and effector (CD28+CD95+ and CD28−CD95+/−) CD4+ T cells 2 weeks after recall MML vaccinations by production of CD40L, IFNγ, IL-2, TNFα, or a combination. (A) Pie charts represent fraction of cells that have 4 (yellow), 3 (cyan), 2 (blue), or 1 (purple) function(s). P value calculated by partial permutation test. (B) Delineation of the 15 possible cytokine combinations is shown for SIV− (green) and SIV+ (black). Dots represent individual RM responses. (C) Student t test results between SIV− and SIV+ cytokine responses corresponding to panel B. Pink shading represents a significant P value less than .05. (D) Total frequency of cytokine producing memory and effector CD4+ T cells for SIV− (green) and SIV+ (black) in response to MML stimulation. P values represent partial permutation test results (A) or Student t test results (C).
Figure 3
MML-specific CD4+ T cells are not preferentially infected with SIV 2 weeks after MML vaccination. CD4+ T cells from SIV-infected RMs were sorted into 4 populations: naive (circles), memory (squares), effector (triangles), and MML-specific (inverted triangles) cells. Quantitative real-time PCR was used to determine the SIV infection frequency of each subset after neo MML vaccination (A) or recall MML vaccination (B). Horizontal bar represents median.
Figure 4
Overall CD4+ T cell functionality is decreased after SIV infection. Flow cytometric analysis of SEB-stimulated memory and effector (CD28+CD95+ and CD28−CD95+/−) CD4+ T cells by production of CD40L, IFNγ, IL-2, TNFα, or a combination. (A) Pie charts represent fraction of cells that have 4 (yellow), 3 (cyan), 2 (blue), or 1 (purple) function(s). P value represents partial permutation test. (B) Delineation of the 15 possible cytokine combinations is shown for SIV− (green) and SIV+ (black). Dots represent individual RM responses. (C) Student t test results between SIV− and SIV+ cytokine responses corresponding to panel B. Pink shading represents a significant P value less than .05. (D) Total frequency of cytokine producing memory and effector CD4+ T cells for SIV− (green) and SIV+ (black) RMs in response to SEB stimulation. P values represent partial permutation test results (A) or Student t test results (C). SEB responses from uninfected animals are based on data from group 1 and group 3 animals before SIV infection.
Figure 5
MML-specific cmASCs are altered after SIV infection. ELISpot analysis of classic memory (CD27+) B-cell Ig responses (cmASCs). (A-B) Specific for MML or (C) total Ig (heavy and light chain, positive control). (A) Number (per 106 cells) of MML-specific cmASCs 2 weeks after neo MML vaccination for IgG (left), IgM (center), or IgA (right). (B) Number (per 106 cells) of MML-specific cmASCs 2 weeks after recall MML vaccination for IgG (left), IgM (center), or IgA (right). (C) Number (per 106 cells) of total Ig cmASCs 2 weeks after neo or recall MML vaccination for IgG (left), IgM (center), or IgA (right). SIV− RMs (circles) and SIV+ RMs (squares). P values represent Mann-Whitney U t test results, horizontal bar represents median. For one animal (CE5D), we did not have sufficient cells to perform the IgA assay.
Figure 6
CD4+ Tfh cells are preferentially SIV-infected in LNs. CD4+ T cells from LNs of SIV-infected RMs were sorted into 3 populations: naive (circles), central memory (squares), and Tfh cells (inverted triangles). Quantitative real-time PCR was used to determine the SIV infection frequency of each subset. P values represent Mann-Whitney U t test results. Horizontal bar represents median.
Similar articles
- Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques.
Helmold Hait S, Vargas-Inchaustegui DA, Musich T, Mohanram V, Tuero I, Venzon DJ, Bear J, Rosati M, Vaccari M, Franchini G, Felber BK, Pavlakis GN, Robert-Guroff M. Helmold Hait S, et al. J Virol. 2019 Feb 5;93(4):e01687-18. doi: 10.1128/JVI.01687-18. Print 2019 Feb 15. J Virol. 2019. PMID: 30463978 Free PMC article. - SIV antigen immunization induces transient antigen-specific T cell responses and selectively activates viral replication in draining lymph nodes in retroviral suppressed rhesus macaques.
Hu H, Gama L, Aye PP, Clements JE, Barry PA, Lackner AA, Weissman D. Hu H, et al. Retrovirology. 2011 Jul 13;8:57. doi: 10.1186/1742-4690-8-57. Retrovirology. 2011. PMID: 21752277 Free PMC article. - Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques.
Carnathan D, Lawson B, Yu J, Patel K, Billingsley JM, Tharp GK, Delmas OM, Dawoud R, Wilkinson P, Nicolette C, Cameron MJ, Sekaly RP, Bosinger SE, Silvestri G, Vanderford TH. Carnathan D, et al. J Virol. 2018 Apr 13;92(9):e01760-17. doi: 10.1128/JVI.01760-17. Print 2018 May 1. J Virol. 2018. PMID: 29467313 Free PMC article. - The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet?
Sanders VM. Sanders VM. Brain Behav Immun. 2012 Feb;26(2):195-200. doi: 10.1016/j.bbi.2011.08.001. Epub 2011 Aug 10. Brain Behav Immun. 2012. PMID: 21855626 Free PMC article. Review.
Cited by
- Limited impact of fingolimod treatment during the initial weeks of ART in SIV-infected rhesus macaques.
Pino M, Pagliuzza A, Pampena MB, Deleage C, Viox EG, Nguyen K, Shim I, Zhang A, Harper JL, Samer S, King CT, Cervasi B, Gill KP, Ehnert S, Jean SM, Freeman ML, Lifson JD, Kulpa D, Betts MR, Chomont N, Lederman MM, Paiardini M. Pino M, et al. Nat Commun. 2022 Aug 27;13(1):5055. doi: 10.1038/s41467-022-32698-y. Nat Commun. 2022. PMID: 36030289 Free PMC article. - Gut Microbiome Homeostasis and the CD4 T- Follicular Helper Cell IgA Axis in Human Immunodeficiency Virus Infection.
Onabajo OO, Mattapallil JJ. Onabajo OO, et al. Front Immunol. 2021 Mar 19;12:657679. doi: 10.3389/fimmu.2021.657679. eCollection 2021. Front Immunol. 2021. PMID: 33815419 Free PMC article. Review. - Simian Immunodeficiency Virus Infection of Rhesus Macaques Results in Delayed Zika Virus Clearance.
Vinton CL, Magaziner SJ, Dowd KA, Robertson SJ, Amaro-Carambot E, Karmele EP, Ortiz AM, Starke CE, Mudd JC, Whitehead SS, Best SM, Pierson TC, Hickman HD, Brenchley JM. Vinton CL, et al. mBio. 2019 Dec 3;10(6):e02790-19. doi: 10.1128/mBio.02790-19. mBio. 2019. PMID: 31796542 Free PMC article. - SIV-specific CD8+ T cells are clonotypically distinct across lymphoid and mucosal tissues.
Starke CE, Vinton CL, Ladell K, McLaren JE, Ortiz AM, Mudd JC, Flynn JK, Lai SH, Wu F, Hirsch VM, Darko S, Douek DC, Price DA, Brenchley JM. Starke CE, et al. J Clin Invest. 2020 Feb 3;130(2):789-798. doi: 10.1172/JCI129161. J Clin Invest. 2020. PMID: 31661461 Free PMC article. - Simian-Human Immunodeficiency Virus SHIV.CH505 Infection of Rhesus Macaques Results in Persistent Viral Replication and Induces Intestinal Immunopathology.
Bar KJ, Coronado E, Hensley-McBain T, O'Connor MA, Osborn JM, Miller C, Gott TM, Wangari S, Iwayama N, Ahrens CY, Smedley J, Moats C, Lynch RM, Haddad EK, Haigwood NL, Fuller DH, Shaw GM, Klatt NR, Manuzak JA. Bar KJ, et al. J Virol. 2019 Aug 28;93(18):e00372-19. doi: 10.1128/JVI.00372-19. Print 2019 Sep 15. J Virol. 2019. PMID: 31217249 Free PMC article.
References
- Centlivre M, Sala M, Wain-Hobson S, Berkhout B. In HIV-1 pathogenesis the die is cast during primary infection. AIDS. 2007;21(1):1–11. - PubMed
- Douek DC, Brenchley JM, Betts MR, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature. 2002;417(6884):95–98. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous